Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 3A enzymes (CYP3A) are a subfamily of monooxygenase enzymes responsible for metabolizing a large proportion of pharmaceutical drugs, as well as endogenous compounds such as steroid hormones and fatty acids. They are primarily expressed in the liver and intestine, and their activity is subject to genetic polymorphisms and environmental factors, leading to significant inter-individual variability in drug response and potential drug-drug interactions. Major human isoforms include CYP3A4, CYP3A5, CYP3A7, and CYP3A43.
Oxidation (mainly hydroxylation and epoxidation) of substrates using NADPH and molecular oxygen as cofactors.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 3A Enzyme (CYP3A).